Bioprocess Containers (BPCs) Market Pegged At US$ 2.95 billion (2021) Set to Skyrocket With 25% CAGR in Next 5 Years

The Global Bioprocess Containers Market pegged at US$ 2.95 billion (2021) is expected to reach US$ 27.5 billion by 2031, growing at a CAGR of 25% from 2021 to 2031.

Burgeoning biologics & vaccines market, reduced risk of cross-contamination, reduction in the cost of goods sold (COGS), operational benefits (such as reduced setup, maintenance, and validation times), ready integration, and scalability offered by bioprocess containers and growing biopharmaceutical R&D are some of the pivotal factors fueling the Global Bioprocess Containers Market.

However, the issue of leachables & extractables is likely to hinder the growth of the market to a certain extent.

Clairvoyance Research conducted an in-depth market analysis study of the Global Bioprocess Containers Market. The study comprehensively analyzes the market from different perspectives and provides granular insights on hot revenue pockets, headwinds & tailwinds impacting the market, quantitative (market size & forecasts), and qualitative analysis on different segments, key strategies, and competitive landscape.

Access ‘Sample Pages’ of the Report

Biopharmaceutical development and manufacturing is a complex and highly competitive process. Biomanufacturers are challenged to develop targeted therapies, tackle cost pressures related to existing processes, and improve productivity. They are continuously striving to maximize yield, increase efficiency & quality, use existing assets more flexibly, and reduce variability. The advent of single-use technologies has enabled bio manufacturers to attain many of these outcomes, offering benefits of flexibility, process economy, and minimized cleaning.

Bioprocess Containers (BPCs) are ready-to-use single-use flexible container systems for critical liquid handling applications in biopharmaceutical and biomanufacturing operations. These containers are used in cell-culture applications and protein-based drug production for mixing, storage, and transportation of bioprocess fluids and bioreactors. Single-use bioprocessing components eradicate the risk of batch-to-batch cross-contamination and significantly reduce startup costs for bio manufacturers.

Value Proposition of Single-Use Bioprocessing Technologies, Burgeoning Biologics & Vaccines Market and Anticipated Expiry of Biologics Patents Set to Catapult the Global Bioprocess Containers Market

Lower capital expenses, lower operating costs, faster processes, speed to market, reduced energy consumption, and an opportunity for power generation from single-use technologies product waste stream are some of the key benefits of single-use technologies that are increasingly being recognized by the biologics and vaccine industries.

Government regulators across the globe also recognize the benefits of single-use technologies, including reduced investment requirements, lower risk of cross-contamination, and reduced requirements for validated cleaning protocols.

The development of biologics warrants high sterility and therefore biologics are now increasingly being manufactured using single-use technologies.

Single-use systems are also used in biosimilar development. Anticipated expiry of oncology biologics and subsequent launch of biosimilar drugs is another key factor that is expected to fuel the global bioprocess containers market. Patents of around 20 oncology biologics are expected to expire by 2023.

“The single-use market is evolving rapidly and is projected to continue to grow by double digits in the foreseeable future.

Single-use technologies (SUT) are coming more and more central in modern pharmaceutical manufacturing design, as they may improve the change towards new production models characterized by enhanced safety and simplified operations.

Adopting a single-use Bioprocess Containers (BPC)-based manufacturing system could result in overall capital saving of about 20-40 percent over the traditional Stainless Steel (SS) fixed tank set-up.”

- VP and GM of Single-Use Technologies, Leading Bioprocess Containers Manufacturer, U.S.

Snapshot - Competitive Landscape

The Bioprocess Containers Market is marked by the presence of prominent players such as Thermo Fisher Scientific, Sartorius Stedim Biotech, Merck Millipore, Danaher Corporation, among others.

For deep-rooted insights, please follow the Link

NEED MORE?

• Talk to us about your requirements and get a customized report
• Get more details about the content of the report
• Request ‘Sample Pages’ of the report